Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.85437 | 36 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.83719 | 37 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.84354 | 37 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.76281 | 36 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.81304 | 38 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.8654 | 35 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.83713 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.82176 | 37 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.78685 | 35 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.83437 | 37 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.82602 | 37 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.81909 | 37 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.82749 | 36 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.83096 | 37 |